These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 16846086

  • 1. Vulvovaginal candidiasis from non-albicans species: retrospective study of recurrence rate after fluconazole therapy.
    Ventolini G, Baggish MS, Walsh PM.
    J Reprod Med; 2006 Jun; 51(6):475-8. PubMed ID: 16846086
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial).
    Donders G, Bellen G, Byttebier G, Verguts L, Hinoul P, Walckiers R, Stalpaert M, Vereecken A, Van Eldere J.
    Am J Obstet Gynecol; 2008 Dec; 199(6):613.e1-9. PubMed ID: 18976735
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Treatment of chronic recurrent vulvovaginal candidiasis with fluconazole (fungolon--Actavis)].
    Borisov I, Kolarov G, Bobcheva S, Ivanova A.
    Akush Ginekol (Sofiia); 2005 Dec; 44 Suppl 2():17-20. PubMed ID: 16028398
    [Abstract] [Full Text] [Related]

  • 6. Vulvovaginal candidiasis in a Flemish patient population.
    De Vos MM, Cuenca-Estrella M, Boekhout T, Theelen B, Matthijs N, Bauters T, Nailis H, Dhont MA, Rodriguez-Tudela JL, Nelis HJ.
    Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of recurrent vulvovaginal candidosis with mycosyst (fluconazole)].
    Pekhlivanov B, Amaliev I, Ivancheva Kh, Zisova L.
    Akush Ginekol (Sofiia); 2005 Dec; 44 Suppl 2():25-7. PubMed ID: 16028400
    [Abstract] [Full Text] [Related]

  • 8. Treatment of recurrent vulvovaginal candidiasis.
    Ringdahl EN.
    Am Fam Physician; 2000 Jun 01; 61(11):3306-12, 3317. PubMed ID: 10865926
    [Abstract] [Full Text] [Related]

  • 9. Clinical resistance of recurrent Candida albicans vulvovaginitis to fluconazole in the presence and absence of in vitro resistance.
    MacNeill C, Weisz J, Carey JC.
    J Reprod Med; 2003 Feb 01; 48(2):63-8. PubMed ID: 12621787
    [Abstract] [Full Text] [Related]

  • 10. An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis.
    Seidman LS, Skokos CK.
    Infect Dis Obstet Gynecol; 2005 Dec 01; 13(4):197-206. PubMed ID: 16338779
    [Abstract] [Full Text] [Related]

  • 11. Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole.
    Sobel JD, Kapernick PS, Zervos M, Reed BD, Hooton T, Soper D, Nyirjesy P, Heine MW, Willems J, Panzer H, Wittes H.
    Am J Obstet Gynecol; 2001 Aug 01; 185(2):363-9. PubMed ID: 11518893
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
    Ray D, Goswami R, Banerjee U, Dadhwal V, Goswami D, Mandal P, Sreenivas V, Kochupillai N.
    Diabetes Care; 2007 Feb 01; 30(2):312-7. PubMed ID: 17259500
    [Abstract] [Full Text] [Related]

  • 13. Recurrent vulvovaginal candidiasis.
    Ringdahl EN.
    Mo Med; 2006 Feb 01; 103(2):165-8. PubMed ID: 16703718
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for recurrent vulvovaginal candidiasis in women receiving maintenance antifungal therapy: results of a prospective cohort study.
    Patel DA, Gillespie B, Sobel JD, Leaman D, Nyirjesy P, Weitz MV, Foxman B.
    Am J Obstet Gynecol; 2004 Mar 01; 190(3):644-53. PubMed ID: 15041994
    [Abstract] [Full Text] [Related]

  • 15. [Comparative study of itraconazole and fluconazole therapy in vaginal candidosis].
    Vacheva-Dobrevski R, Kovachev S, Nacheva A, Stoev S, Vasilev N.
    Akush Ginekol (Sofiia); 2004 Mar 01; 43(1):20-3. PubMed ID: 15168649
    [Abstract] [Full Text] [Related]

  • 16. Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy.
    Shahid Z, Sobel JD.
    Diagn Microbiol Infect Dis; 2009 Jul 01; 64(3):354-6. PubMed ID: 19501794
    [Abstract] [Full Text] [Related]

  • 17. Evolution of vaginal Candida species recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis: the emergence of Candida glabrata? Terry Beirn Community Programs for Clinical Research in AIDS (CPCRA).
    Vazquez JA, Sobel JD, Peng G, Steele-Moore L, Schuman P, Holloway W, Neaton JD.
    Clin Infect Dis; 1999 May 01; 28(5):1025-31. PubMed ID: 10452629
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of fluconazole and nystatin in the treatment of vaginal Candida species.
    Martins HP, da Silva MC, Paiva LC, Svidzinski TI, Consolaro ME.
    Acta Derm Venereol; 2012 Jan 01; 92(1):78-82. PubMed ID: 21918792
    [Abstract] [Full Text] [Related]

  • 19. Candida tropicalis vulvovaginitis.
    Horowitz BJ, Edelstein SW, Lippman L.
    Obstet Gynecol; 1985 Aug 01; 66(2):229-32. PubMed ID: 3895072
    [Abstract] [Full Text] [Related]

  • 20. Trends in prescribing for vulvovaginal candidiasis in the United States.
    McCaig LF, McNeil MM.
    Pharmacoepidemiol Drug Saf; 2005 Feb 01; 14(2):113-20. PubMed ID: 15386715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.